US Patent Issued to TOSOH, SAGAMI CHEMICAL RESEARCH INSTITUTE on April 7 for "Fucose-binding protein, method for producing same, and use of same" (Japanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,286, issued on April 7, was assigned to TOSOH Corp. (Yamaguchi, Japan) and SAGAMI CHEMICAL RESEARCH INSTITUTE (Kanagawa, Japan). "Fucose-bi... Read More

US Patent Issued to Yale University on April 7 for "Leptospiral proteins and uses thereof" (Connecticut Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,287, issued on April 7, was assigned to Yale University (New Haven, Conn.). "Leptospiral proteins and uses thereof" was invented by Joseph ... Read More

US Patent Issued to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES on April 7 for "Vasopressin-2 receptor antagonist peptides and uses thereof" (French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,288, issued on April 7, was assigned to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (Paris). "Vasopressin-2 receptor ant... Read More

US Patent Issued to TOKUSHIMA UNIVERSITY, ONCOTHERAPY SCIENCE on April 7 for "Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2" (Japanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,289, issued on April 7, was assigned to TOKUSHIMA UNIVERSITY (Tokushima, Japan) and ONCOTHERAPY SCIENCE INC. (Kawasaki, Japan). "Therapeuti... Read More

US Patent Issued to FRED HUTCHINSON CANCER CENTER, JUNO THERAPEUTICS on April 7 for "T cell receptors specific for mesothelin and their use in immunotherapy" (Washington Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,290, issued on April 7, was assigned to FRED HUTCHINSON CANCER CENTER (Seattle) and JUNO THERAPEUTICS INC. (Seattle). "T cell receptors spe... Read More

US Patent Issued to A2 BIOTHERAPEUTICS on April 7 for "Engineered immune cells with micro-clusters" (California Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,291, issued on April 7, was assigned to A2 BIOTHERAPEUTICS INC. (Agoura Hills, Calif.). "Engineered immune cells with micro-clusters" was i... Read More

US Patent Issued to BIONTECH CELL & GENE THERAPIES on April 7 for "Interleukin-2 receptor (IL2R) and interleukin-2 (IL2) variants for specific activation of immune effector cells" (German Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,292, issued on April 7, was assigned to BIONTECH CELL & GENE THERAPIES GMBH (Mainz, Germany). "Interleukin-2 receptor (IL2R) and interleuki... Read More

US Patent Issued to The Wistar Institute on April 7 for "Anti-follicle stimulating hormone receptor antibodies" (Pennsylvania Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,293, issued on April 7, was assigned to The Wistar Institute (Philadelphia). "Anti-follicle stimulating hormone receptor antibodies" was in... Read More

US Patent Issued to Hoffmann-La Roche on April 7 for "Methods to decrease impurities from recombinant protein manufacturing processes" (German Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,294, issued on April 7, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Methods to decrease impurities from recombinant prote... Read More

US Patent Issued to Prothena Biosciences, Hoffmann-La Roche on April 7 for "Dosing regimes for treatment of synucleinopathies" (American, Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,295, issued on April 7, was assigned to Prothena Biosciences Ltd. (Dublin) and Hoffmann-La Roche Inc. (Little Falls, N.Y.). "Dosing regimes... Read More

• ««
• «
• 138533
• 138534
• 138535
• 138536
• 138537
• 138538
• 138539
• 138540
• 138541
• 138542
• »
• »»